Cncr stock price

23 May 2019 A discounted health stock that's hiding in plain sight. Immunotherapy ETF ( Nasdaq: CNCR) owns 25 stocks focused on curing some form of cancer. Trading since 2015, it hit its lowest price ever during last year's sell-off.

CNCR - Loncar Cancer Immunotherapy ETF - Holdings - Zacks.com CNCR: Loncar Cancer Immunotherapy ETF - Fund Holdings. Get up to date fund holdings for Loncar Cancer Immunotherapy ETF from Zacks Investment Research CNCR | ETF Snapshot - Fidelity The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 25 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight … CNCR -- Is Its Stock Price A Worthy Investment? Learn More. The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.

Mar 19, 2020 · Stock quote for Loncar Cancer Immunotherapy ETF Common Stock (CNCR) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

View live ETF SERIES SOLUTIONS LONCAR CANCER IMMUNOTHERAPY ETF chart to track its stock's price action. Find market predictions, CNCR financials  the key facts, figures, and identifying codes for the Cancer Immunotherapy ETF (Nasdaq: CNCR). Index Symbol, LCINDX Closing Price, $18.77 The Hong Kong Stock Exchange (HKEX) is the primary stock exchange in the Hong Kong  18 Mar 2020 Even before the crash, the average share price of the 18 was just 2.87. Company, Ticker, Index Constituents [Primary Listing], Stock Price On 3/18/2020, Sector, YTD Ch CNCR, Loncar Cancer Immunotherapy ETF, -17.5%. We apologize for any inconvenience. Refresh or try again later. TG Therapeutics Stock Climbs After Successfully Completed Analysis in UNITY-CLL. 31 Oct 2019 1 -- CNCR-IT's stock price climbed this morning after the Chinese firm said that Alibaba Group Holding's cloud computing arm will become the 

Prev Close 20.01, 52 Wk Low 12.00. Open 19.32, 52 Wk High 24.57. Day Low 19.32, Volume 25,934.00. Day High 20.01, Avg 10D Vol 17,419.00 

Loncar Cancer Immunotherapy ETF (CNCR) Stock Analysis ... Get breaking news and analysis on Loncar Cancer Immunotherapy ETF (CNCR) stock, price quote and chart, trading and investing tools. CNCR Stock Price, Forecast & News (Loncar Cancer ... Researching Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR) stock? View CNCR's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. CNCR Stock Price, Forecast & News (Loncar Cancer ...

CNCR - Loncar Cancer Immunotherapy ETF - Holdings - Zacks.com

This is CNCR Loncar Cancer Immunotherapy ETF, it is trading +25% year to date, some of its 30 holdings are ATRA, IOVA, NKTR, JNCE, BGNE, ACEN, 64% in Micro Cap, last price $30.60, expense ratio 0.79%. CNCR | Loncar Cancer Immunotherapy ETF Stock Price, Quotes ... View the latest Loncar Cancer Immunotherapy ETF (CNCR) stock price and news, and other vital information for better exchange traded fund investing. Dow Jones, a News Corp company. Loncar Cancer Immunotherapy ETF (CNCR) Stock Analysis ... Get breaking news and analysis on Loncar Cancer Immunotherapy ETF (CNCR) stock, price quote and chart, trading and investing tools. CNCR Stock Price, Forecast & News (Loncar Cancer ...

in global and emerging markets. Identify ETFs which hold a specific stock Symbol, Prospectus, Volume, Today's Change, 5-Day Trend, Last, 52-Wk Range  

If you are looking for stocks with good return, Cncr can be a profitable investment option. Cncr quote is equal to 22.040 USD at 2020-02-10. Based on our forecasts, a long-term increase is expected, the "CNCR" stock price prognosis for 2025-02-05 is 53.439 USD. With a 5-year investment, the revenue is expected to be around +142.46%. Loncar Cancer Immunotherapy ETF (CNCR) Related Stocks ... Loncar Cancer Immunotherapy ETF (CNCR) Related Stocks - discover similar stocks, compare dividends and return. Compare momentum and price performance. Loncar Cancer Immunotherapy ETF (CNCR) Balance Sheet | The ...

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 25 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight … CNCR -- Is Its Stock Price A Worthy Investment? Learn More.